 The study resulted in a hearing in the U.S. House of Representatives four days later and major U.S. newspapers and network news programs, where device industry representatives argued that clinical trials were not needed and the cost of doing the studies would interfere with job growth and innovation.In April 2011, Center president Diana Zuckerman testified before the U.S. Senate Special Committee on Aging about the study findings.In 2014, Center staff published a study in the peer-reviewed JAMA Internal Medicine about the scientific evidence submitted to the FDA to support the marketing of implanted medical devices under the agency’s 510(k) review process.